Article Text

PDF

Gastrointestinal cancers accompanied by a dense lymphoid component: an overview with special reference to gastric and colonic medullary and lymphoepithelioma-like carcinomas
  1. Runjan Chetty
  1. Correspondence to Professor Runjan Chetty, Department of Cellular Pathology, Oxford University Hospitals/University of Oxford/Oxford Biomedical Research Centre, Level 1, Academic Centre, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; runjan.chetty{at}ndcls.ox.ac.uk

Abstract

This review highlights the difference between so-called medullary carcinoma and lymphoepithelioma-like carcinoma with reference to the gastrointestinal tract. The two terms have been applied synonymously in the gastrointestinal tract, with the majority of carcinomas associated with lymphocytes being termed medullary carcinomas. True medullary carcinomas are disposed in syncytial sheets and have well defined peripheral margins; the preponderance of inflammation is peri-tumoural. These tumours are also associated with microsatellite instability (MSI). Lymphoepithelioma-like carcinomas tend not to have continuous sheets of tumour but are instead made up of small clusters and aggregates of tumour that are broken up by large numbers of intra-tumoural lymphocytes. These tumours may be associated with Epstein–Barr virus (EBV). Occasional cases may be associated with epigenetic silencing of MLH-1. In conclusion, carcinomas associated with dense lymphoid stroma maybe associated with either MSI or EBV. There are some morphological features that favour either type and in the stomach MSI and EBV are mutually exclusive.

  • Gastrointestinal Disease
  • Gastric Cancer
  • Colorectal Cancer

Statistics from Altmetric.com

Historical aspects and origins of the term ‘medullary carcinoma’

One of the earliest uses of the word ‘medullary’ in medicine was not as a description of a tumour or some other abnormal condition but rather as a type of normal tissue according to Bichat (General Anatomy Applied to Physiology and Medicine, published in 1801; Professor Juan Rosai, personal communication).

Johannes Muller listed four major types of cancers in 1843: scirrhous, medullary sarcoma, alveolar cancer, and melanotic cancer. Muller's medullary sarcoma was regarded as synonymous with encephaloid cancer and medullary carcinoma (Professor Juan Rosai, personal communication).

The term ‘medullary’ carcinoma had now entered the medical lexicon on the basis of a variant of breast cancer with microscopic resemblance to the normal medulla oblongata1 ,2 (figure 1). Medullary carcinoma has a low power appearance that highlights the interplay between the inner pale, solid area (corresponding to the cancer) with the surrounding darker zone (corresponding to the lymphoid infiltrate) of the normal medulla oblongata. Some have mistakenly related so-called ‘encephaloid’ breast cancer with medullary cancer in view of the soft and pale gross appearance that is reminiscent of brain tissue. It would appear that the first description of medullary carcinoma is ascribed to Geschickter, who described a breast cancer with a high survival rate that was accompanied by a dense lymphoid infiltrate.3 The actual appellation, ‘medullary carcinoma’, to describe this unique breast cancer was first used by Foote and Stewart in their classic treatise on the histological classification of breast cancers, and then reinforced three years later by Moore and Foote.1 ,2 It is interesting to note that even in 1949, Moore and Foote were moved to comment that the word ‘medullary’, when applied to mammary carcinoma, has been ‘variously used by different writers’.2

Figure 1

A cross section through the medulla oblongata showing a festooning pale area rimmed by a darker cuff. Medullary carcinomas are thought to resemble this by having syncitia of large cells (light areas) surrounded by a peripheral zone of lymphoid cells (darker areas). (Image courtesy of Dr Olaf Ansorge, Department of Neuropathology, Oxford University Hospitals and University of Oxford.)

With regard to the gastrointestinal (GI) tract, the first reference to a tumour similar to that occurring in the breast was called a ‘blue cell tumour’ by Steiner et al in 1948,4 but the use of the term medullary carcinoma for an unusual variant of gastric cancer is ascribed to Hamazaki and colleagues, who published this description in the Japanese literature (quoted by Shimizu et al).5 ,6 Subsequently, more cases of gastric medullary carcinoma were described, emanating mainly from Japan.7 ,8 Later, cases of medullary carcinoma were also described in the colon.9 ,10

Morphological diagnostic criteria for medullary carcinoma

In the breast, three systems or sets of criteria were suggested for a histological diagnosis of medullary carcinoma. These were proposed by Ridolfi et al, Wargotz and Silverberg, and Pedersen et al.11–13 All three classification schemes are underpinned by common histological features: (a) syncytial growth pattern of the tumour cells in more than 75% of the tumour, (b) admixed lymphoplasmacytic infiltrate, (c) microscopic circumscription, (d) grade 2 or grade 3 nuclei, and (e) absence of glandular differentiation (figure 2).

Figure 2

An example of a medullary carcinoma composed of large cells arranged in a diffuse sheet. The edge of the tumour is well defined and regular. The preponderance of lymphocytes is at the periphery of the tumour. Scattered intra-tumoural lymphocytes are also noted.

In assessing microscopic circumscription of the tumour, it is important to examine the leading edge of the tumour rather than the peri-tumoural lymphocytic response, which may appear slightly irregular. The leading edge of the tumour is non-infiltrative.

Tumours that lack a variable number of these characteristics (depending on the system used) are classified as either atypical medullary carcinoma or invasive ductal carcinoma. The Ridolfi system has the most stringent criteria while the Pedersen system the least stringent. An essential feature is the syncytial growth pattern which Ridolfi and colleagues described as ‘broad, interanastomosing sheets of tumour cells’.11 Wargotz and Silverberg refined this a little by stating the syncytial pattern should be composed of ‘broad confluent bands of tumour cells more than five cells thick, often with indistinct cell borders’.12 Even the two-criteria system advocated by Pedersen et al,13 contained a syncytial growth pattern as one of the two criteria.

Gastrointestinal medullary carcinoma

The initial descriptions of medullary carcinoma in the stomach and colon have remained faithful to the morphological diagnostic criteria established for their breast counterparts.

Jessurun and colleagues stated quite categorically that ‘tumours were accepted as medullary adenocarcinomas if on histological examination at least 80% showed a solid pattern, had a nested, organoid, or trabecular growth pattern mimicking endocrine carcinomas, and were formed by small round to polygonal uniform cells with scant eosinophilic or amphophilic cytoplasm and rounded nuclei with small central nucleoli’.10 They did not include a lymphocytic component as a diagnostic criterion, but all 11 of their cases were associated with a lymphocytic response, which was intense peri- and intra-tumoural in eight cases.10

The next major study on medullary carcinomas of the GI tract was undertaken by Wick and colleagues.14 Their selection criteria for medullary carcinoma were as follows: the tumours ‘were required to demonstrate sheets, nests, and trabeculae of large polygonal cells with high nuclear/cytoplasmic (N/C) ratios and amphophilic cytoplasm, with variably interspersed mature lymphocytes. Nuclei were vesicular, with prominent nucleoli’.15 This study stressed two important features. First, medullary carcinoma of the colon had a characteristic scanning magnification appearance that is best described as ‘organoid’, simulating the growth pattern of developing embryonic organs. Second, they emphasised the similarity to neuroendocrine carcinoma morphologically (nested, organoid growth pattern) and immunophenotypically, with over 30% of their cases showing immunohistochemical evidence of neuroendocrine differentiation.14

Thus, an organoid or solid or sheet-like or trabecular pattern, and peri- and intra-tumoural lymphocytes are required to make a diagnosis of medullary carcinoma.

Medullary carcinomas of the colon and stomach, and microsatellite instability

Medullary carcinomas of the colon became the focus of attention following the discovery of microsatellite instability (MSI) in a cohort of right-sided inherited and sporadic colon cancers. In the setting of Lynch syndrome (hereditary non-polyposis colorectal carcinomas, HNPCC), several of the cancers were noted to be associated with dense Crohn's-like lymphoid aggregates.16 In the first detailed pathological examination of sporadic colon cancers showing replicative errors, Kim and colleagues encountered three undifferentiated carcinomas that fulfilled the criteria for medullary carcinomas.15 Alexander et al17 also confirmed that a medullary phenotype identifies colorectal cancer with MSI. Thus, a characteristic constellation of morphological features in colon cancer (including colonic medullary carcinoma) was indicative of the molecular status/pathogenesis of the cancer.

Those medullary carcinomas occurring in the colon have a predilection for the right colon and the characteristic morphology flags a subset of tumours that are microsatellite unstable. A similar association exists between similar appearing medullary gastric cancers and MSI.18

Epstein–Barr virus-associated gastric cancer (‘lymphoepithelioma-like cancer’)

At this juncture it is worth noting that no mention is made of an association between true medullary carcinoma (in any site, including the stomach) and Epstein–Barr virus (EBV). Specifically addressing the question whether EBV was implicated in medullary breast cancer, two studies demonstrated clearly that there was no connection between bona fide medullary breast cancer and EBV.19 ,20

The term ‘lymphoepithelioma’ was coined in 1921 by Regaud and Reverchon21 and Schminke22 to describe a tumour occurring in the nasopharynx. This tumour characteristically is composed of cells with large vesicular nuclei, single prominent nucleoli and indistinct cell borders, which impart a syncytial appearance to the tumour, and it has an attendant lymphoplasmacytic inflammatory component.23 Following from these seminal observations, two histological patterns are apparent. In the Regaud pattern the tumour is arranged in nests, while in the Schminke pattern isolated tumour cells within the characteristic inflammatory infiltrate are encountered. With this phenotypic hallmark, lymphoepithelioma-like carcinomas outside the nasopharynx were soon described: thymus, skin, uterine cervix, lung, salivary gland, breast etc., but the vast majority of these cases were not associated with EBV infection.

Burke et al23 first described a ‘lymphoepithelial carcinoma’ of the stomach that was associated with EBV. Then in 1991, two studies from the same group described undifferentiated gastric carcinoma that was associated with EBV.24 ,25 In both of these papers the authors clearly refer to the cancers as being ‘lymphoepithelioma-like carcinomas’ because they bore a resemblance to nasopharyngeal carcinoma, both histologically and because of the EBV association.

Lymphoepithelioma-like carcinomas of the breast that have been described in the literature thus far have not demonstrated an association with EBV.26–30

It is worth reiterating that unlike medullary carcinomas, these lymphoepithelioma-like carcinomas in the breast were characterised by tumour cells forming small clusters, nests or sheet-like growth patterns with unclear margins because they were permeated by numerous lymphocytes (figure 3). These findings do not correspond to the syncytial growth patterns seen in medullary carcinoma. Furthermore, the lymphoid infiltrate tended to be more intra-tumoural than peri-tumoural in lymphoepithelioma-like carcinoma of the breast and other sites. In medullary carcinomas, the converse is true.

Figure 3

Lymphoepithelioma-like carcinoma is often composed of small clusters of tumour with a pervasive intra-tumoural lymphoid response. The edge of the tumour is infiltrative and irregular.

Thus, in the stomach, carcinomas with a lymphoid stroma are either associated with MSI (medullary carcinoma) or EBV (lymphoepithelioma-like carcinoma). As mentioned, there are morphological features that allow for their separation.

In 1994, a study by Takano et al31 was published under the title, ‘Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach’. However, scrutiny of the image and accompanying legend tends to suggest that the tumour depicted is a lymphoepithelioma-like carcinoma rather than a medullary carcinoma.31 The tumour that is illustrated has a prominent intra-tumoural lymphocytic response. Furthermore, ‘gland formation, usually in acinar or trabecular fashion’ was noted in 18 of the 30 cases. It is quite conceivable that some of the cases in the series were, in fact, not medullary carcinomas but EBV-driven lymphoepithelioma-like carcinomas since 90% of their cases were Epstein Barr encoded RNA-in situ hybridisation (EBER-ISH) positive.31

MSI and EBV in gastric cancers with lymphoid stroma

Grogg and colleagues explored the relationship between EBV and MSI in the setting of lymphocyte-rich gastric cancers.32 Although their numbers were small, an interesting conclusion emanating from their study was that EBV and MSI were mutually exclusive. In other words, none of the tumours that were EBV-positive were MSI-high.32 Similar findings were obtained in the study by Leung et al.33

These studies lend credence to the notion that there are two separate pathways involved in the genesis of medullary carcinomas and lymphoepithelioma-like carcinomas of the stomach. Although they are united by the presence of lymphoid cells, there are other morphological and pathogenetic differences that allow for their separation. In the stomach it appears safe to assume that not all gastric cancers with a lymphoid stroma are medullary carcinomas. Indeed, if such a cancer is not MSI high, it will more than likely be EBV-positive, and vice versa. The morphology also faithfully recapitulates these different pathogenetic lines: medullary carcinomas being organoid, syncytial and sheet-like with a pushing non-infiltrative tumour front with a dense peri-tumoural lymphocytic infiltrate, while lymphoepithelioma-like carcinoma is composed of single cells, small clusters of cells and small glands with an infiltrative growth pattern and a dense intra-tumoural lymphoid infiltrate.

Lymphoepithelioma-like carcinoma of the colon

Thus far, only six cases of lymphoepithelial lesion (LEL) carcinoma have been documented in the colon and the association with EBV has been inconsistent.34–39 In fact, the majority of cases, as with several examples of lymphoepithelioma-like carcinoma outside of the nasopharynx/stomach (non-foregut examples), are not associated with EBV. A case of lymphoepithelioma-like carcinoma of the colon has been described in a patient with HNPCC.36 From the description of the tumour, it would appear to conform to the criteria for a lymphoepithelioma-like carcinoma rather than a medullary carcinoma.36 The patient had additional features such as high-grade tubular adenomas and a mucinous carcinoma. Furthermore, because of the lymphoepithelioma-like morphology, EBV infection was sought and found to be negative.36 This does appear to be a unique case and others have not found significant levels of MSI in lymphoepithelioma-like carcinomas of the lung, for instance.40 There are cases of colonic lymphoepithelioma-like carcinomas of the colon that are not arranged in syncytial sheets but rather as single cells, small clusters of tumour and occasional glands that have a predominant intra-tumoural lymphoid component. Such a case was EBV negative but showed loss of MLH1 and PMS2 proteins and was deemed to be due to epigenetic loss of these proteins.39

Conclusions

As the molecular pathways involved in colorectal carcinogenesis are unravelled, the prevailing wisdom is that three distinct pathways exist: the chromosomal instability, MSI and the CpG island methylator phenotype pathways. The latter two are associated with cancers that have a prominent lymphoid component. Lymphoepithelioma-like cancer, if not related to EBV, then may be due to sporadic epigenetic silencing of MLH-1.

As with many terms that are entrenched in medicine, contemporary advances have rendered them somewhat obsolete. Perhaps it would be simpler to classify a tumour with a prominent intra- or peri-tumoural lymphoid component as an adenocarcinoma with lymphoid stroma with or without MSI, or with or without associated EBV. There is persuasive evidence that MSI and EBV infection are mutually exclusive, especially in gastric adenocarcinomas with a lymphoid stroma. There is merit in separating the two entities because of their different aetiopathogenesis, genetic screening and potential therapeutic implications.

Take-home messages

  • There is strong molecular evidence that supports separating medullary carcinomas from lymphoepithelioma-like cancers.

  • All cancers accompanied by significant lymphocytes that occur in the colon should not simply be regarded as medullary carcinomas.

  • Both medullary and lymphoepithelioma-like carcinomas of the gastrointestinal tract have slightly different morphological criteria and are underpinned by distinct molecular pathways.

  • Medullary carcinomas are usually associated with MSI, while lymphoepithelioma-like carcinomas may or may not be Epstein–Barr virus-driven.

References

View Abstract

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.